Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: Restoration by MK-801 or dynorphin antiserum

Brain Research

Volumn 831, Issue 1-2, 1999, Pages 55-63

  Bian, Di ^a   Ossipov, Michael H ^a   Ibrahim, Mohab ^a   Raffa, Robert B ^b,c   Tallarida, Ronald J ^c   Malan Jr , T Philip ^a   Lai, Josephine ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allodynia; Dynorphin; MK 801; Morphine; Nerve injury; Supraspinal spinal synergy

Indexed keywords

DIZOCILPINE; DYNORPHIN ANTIBODY; MORPHINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HYPERALGESIA; IMMUNOREACTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; NERVE INJURY; NERVE LIGATION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANALGESICS, OPIOID; ANIMALS; DIZOCILPINE MALEATE; DRUG SYNERGISM; DYNORPHINS; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNE SERA; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MORPHINE; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVES; RATS; RATS, SPRAGUE-DAWLEY; TOUCH;

EID: 0033549244     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01393-1     Document Type: Article

References (54)

1. S. Arner, B.A. Meyerson, Lack of analgesic effect on neuropathic and idiopathic forms of pain, Pain 33 (1988) 11-23.
2. R. Bakshi, A.I. Faden, Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects, Neurosci. Lett. 110 (1990) 113-117.
3. R. Bakshi, A.I. Faden, Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis, Brain Res. 507 (1995) 1-5.
4. D. Bian, M.L. Nichols, M.H. Ossipov, J. Lai, F. Porreca, Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats, NeuroReport 6 (1995) 1981-1984.
5. D. Bian, M.H. Ossipov, T.P. Malan, F. Porreca, Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury, Neurosci. Lett. 241 (1998) 79-82.
6. R.M. Caudle, L. Isaac, A novel interaction between dynorphin(1-13) and N-methyl-D-aspartate, Brain Res. 443 (1988) 329-332.
7. S.R. Chaplan, F.W. Bach, J.W. Pogrel, J.M. Chung, T.L. Yaksh, Quantitative assessment of tactile allodynia in the rat paw, J. Neurosci. Methods 53 (1994) 55-63.
8. L. Chen, Y. Gu, L.Y. Huang, The mechanism of action of for the block of NMDA receptor channels by the opioid peptide dynorphin, J. Neurosci. 15 (1995) 4602-4611.
9. L. Chen, Y. Gu, L.Y. Huang, The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat, J. Physiol. 482 (1995) 575-581, Part 3.
10. L. Chen, Y. Gu, L.Y. Huang, Dynorphin block of N-methyl-D-aspartate channels increases with the peptide length, J. Pharmacol. Exp. Ther. 284 (1998) 826-831.
11. S.N. Davies, D. Lodge, Evidence for involvement of Af-methyl-aspartate receptors in 'wind-up' of class 2 neurons in the dorsal horn of the rat, Brain Res. 424 (1987) 402-406.
12. M. Devor, C.H. Keller, M.H. Ellisman, Spontaneous discharge of afferents in a neuroma reflects original receptor tuning, Brain Res. 517 (1990) 245-250.
13. A.H. Dickenson, A.F. Sullivan, Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: differential response to an intrathecal opiate administered pre- or post-formalin, Pain 30 (1987) 349-360.
14. R. Dubner, M.A. Ruda, Activity-dependent neuronal plasticity following tissue injury and inflammation, Trends Neurosci. 15 (1992) 96-103.
15. A.I. Faden, Opioid and non-opioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury, Ann. Neurol. 27 (1990) 67-74.
16. A.I. Faden, T.P. Jacobs, Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action, Br. J. Pharmacol. 81 (1984) 271-276.
17. M. Ibrahim, M.K. Chawla, Z. Chengmin, J. Lai, F. Porreca, T.P. Malan, Spatial and temporal correlation of spinal dynorphin content with behavioral signs of nerve injury, Soc. Neurosci. Abstr. 24 (1998) 892.
18. S.H. Kim, J.M. Chung, An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat, Pain 50 (1992) 355-363.
19. 2-17 to the NMDA receptor complex, Soc. Neurosci. Abstr. 23 (1997) 941.
20. S.-L. Lai, Y. Gu, M.L.-Y. Huang, Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons, Neurosci. Lett. 247 (1998) 115-118.
21. Y.W. Lee, S.R. Chaplan, T.L. Yaksh, Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model, Neurosci. Lett. 199 (1995) 111-114.
22. H.A. Lekan, S.M. Carlton, R.E. Coggeshall, Sprouting of A beta fibers into lamina II of the rat dorsal horn in peripheral neuropathy, Neurosci. Lett. 208 (1996) 147-150.
23. D. Lima, A. Avelino, A. Coimbra, Morphological characterization of marginal (lamina I) neurons immunoreactive for substance P, enkephalin, dynorphin and gamma-aminobutyric acid in the rat spinal cord, J. Chem. Neuroanat. 6 (1993) 43-52.
24. J.B. Long, J.M. Petras, W.C. Mobley, J.W. Holaday, Neurological dysfunction after intrathecal injection of dynorphin A(1-13) in the rat: II. Non-opioid mechanisms mediate loss of motor, sensory and autonomic function, J. Pharmacol. Exp. Ther. 246 (1988) 1167-1174.
25. J.B. Long, D.D. Rigamonti, M.A. Oleshansky, C.P. Wingfield, A. Martinez-Arizala, Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury, J. Pharmacol. Exp. Ther. 269 (1994) 358-366.
26. J.B. Long, P. Skolnick, 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury, Eur. J. Pharmacol. 261 (1995) 295-301.
27. Y. Miyamoto, N. Morita, Y. Kitabata, T. Yamanishi, S. Kishioka, M. Ozaki, H. Yamamoto, Antinociceptive synergism between supraspinal and spinal sites after subcutaneous morphine evidenced by CNS morphine content, Brain Res. 552 (1991) 136-140.
28. M.L. Nichols, Y. Lopez, M.H. Ossipov, D. Bian, F. Porreca, Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A(1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy, Pain 69 (1997) 317-322.
29. M.H. Ossipov, M.L. Nichols, D. Bian, F. Porreca, Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury, Neurosci. Lett. 199 (1995) 83-86.
30. M.H. Ossipov, Y. Lopez, M.L. Nichols, D. Bian, F. Porreca, The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive, Neurosci. Lett. 199 (1995) 87-90.
31. M.H. Ossipov, Y. Lopez, D. Bian, M.L. Nichols, F. Porreca, Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury, Anesthesiology 86 (1997) 196-204.
32. M.H. Ossipov, T.P. Malan, J. Lai, F. Porreca, Opioid pharmacology of acute and chronic pain, in: A. Dickenson, J.M. Beson (Eds.), Handbook of Experimental Pharmacology, Vol. 130, The Pharmacology of Pain, Springer, Berlin, 1997, pp. 305-333.
33. M.H. Ossipov, D. Bian, F. Porreca, Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats, Pain (1999) in press.
34. 5]enkephalin: a synergistic interaction, Eur. J. Pharmacol. 179 (1990) 463-468.
35. R. Przewlocki, G.T. Shearman, A. Herz, Mixed opioid/non-opioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats, Neuropeptides 3 (1983) 233-240.
36. R.C. Riley, Z.Q. Zhao, A.W. Duggan, Spinal release of immunoreactive dynorphin A(1-8) with the development of peripheral inflammation in the rat, Brain Res. 710 (1996) 131-142.
37. S.C. Roerig, J.M. Fujimoto, L.F. Tseng, Comparisons of descending pain inhibitory pathways activated by beta-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice, J. Pharmacol. Exp. Ther. 247 (1988) 1107-1113.
38. S.C. Roerig, J.M. Fujimoto, Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice, J. Pharmacol. Exp. Ther. 249 (1989) 762-768.
39. M.A. Ruda, M.J. Iadarola, L.V. Cohen, W.S. Young, In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia, Proc. Natl. Acad. SCi. USA 85 (1996) 622-626.
40. L. Stanfa, A. Dickenson, X.-J. Xu, Z. Weisenfeld-Hallin, Cholecystokinin and morphine analgesia: variations on a theme, Trends Pharmacol. Sci. 15 (1994) 65-66.
41. C.W. Stevens, T.L. Yaksh, Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity, J. Pharmacol. Exp. Ther. 238 (1986) 833-838.
42. P. Stewart, L. Isaac, A strychnine-sensitive site is involved in dynorphin-induced paralysis and loss of the tail-flick reflex, Brain Res. 543 (1991) 322-326.
43. J.E. Swett, C.J. Woolf, The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord, J. Comp. Neurol. 231 (1985) 66-77.
44. R.J. Tallarida, R.B. Murray, Manual of Pharmacologic Calculations With Computer Programs, 2nd edn., Springer, New York, 1987, 297 pp.
45. R.J. Tallarida, F. Porreca, A. Cowan, Minireview: statistical analysis of drug-drug and site-site interactions with isobolograms, Life Sci. 45 (1989) 947-961.
46. T.W. Vanderah, T. Laughlin, J.M. Lashbrook, M.L. Nichols, G.L. Wilcox, M.H. Ossipov, T.P. Malan Jr., F. Porreca, Single injection of dynorphin A or des-tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone, Pain (1996) 275-281.
47. R. Wagner, J.A. DeLeo, Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters immunocytochemistry but not allodynia following complete peripheral nerve injury, Neuroscience 72 (1996) 527-534.
48. S. Wegert, M.H. Ossipov, M.L. Nichols, D. Bian, T. Vanderah, T.P. Malan, F. Porreca, Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats, Pain 71 (1997) 57-64.
49. G.L. Wilcox, Excitatory neurotransmitters and pain, in: M.R. Bond, C.J. Woolf (Eds.), Proceedings of the VIth World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 97-117.
50. C.J. Woolf, P. Shortland, R.E. Coggeshall, Peripheral nerve injury triggers central sprouting of myelinated afferents, Nature 355 (1992) 75-78.
51. T.L. Yaksh, T.A. Rudy, Chronic catheterization of the spinal sub-arachnoid space, Physiol. Behav. 17 (1976) 1031-1036.
52. J.C. Yeung, T.A. Rudy, Sites of antinociceptive action of systemically injected morphine: involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone, J. Pharmacol. Exp. Ther. 215 (1980) 626-632.
53. J.C. Yeung, T.A. Rudy, Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine, J. Pharmacol. Exp. Ther. 215 (1980) 633-642.
54. L. Zhang, R.W. Peoples, M. Oz, J. Harvey-White, F.F. Weight, U. Brauneis, Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations, J. Neurophysiol. 78 (1997) 582-590.